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Abstract
Seneca Valley virus 1 (SVV‐1) has been associated with vesicular disease in swine,
with clinical signs indistinguishable from those of other notifiable vesicular dis-
eases such as foot‐and‐mouth disease. Rapid and accurate detection of SVV‐1 is
central to confirm the disease causing agent, and to initiate the implementation of
control processes. The development of rapid, cost‐effective diagnostic assays that
can be used at the point of sample collection has been identified as a gap in pre-
paredness for the control of SVV‐1. This study describes the development and
bench validation of two reverse transcription loop‐mediated amplification (RT‐
LAMP) assays targeting the 5′‐untranslated region (5′‐UTR) and the VP3‐1 region
for the detection of SVV‐1 that may be performed at the point of sample collec-
tion. Both assays were able to demonstrate amplification of all neat samples
diluted 1/100 in negative pig epithelium tissue suspension within 8 min, when
RNA was extracted prior to the RT‐LAMP assay, and no amplification was
observed for the other viruses tested. Simple sample preparation methods using
lyophilized reagents were investigated, to negate the requirement for RNA extrac-
tion. Only a small delay in the time to amplification was observed for these lyo-
philized reagents, with a time from sample receipt to amplification achieved within
12 min. Although diagnostic validation is recommended, these RT‐LAMP assays
are highly sensitive and specific, with the potential to be a useful tool in the rapid
diagnosis of SVV‐1 in the field.
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1 | INTRODUCTION
Seneca Valley virus 1 (SVV‐1) is the only known virus belonging to
the species Senecavirus A, genus Senecavirus, within the family
Picornaviridae (Knowles et al., 2012). It is a non‐enveloped, single‐
stranded, positive‐sense RNA virus recently associated with vesicular
disease in swine in Brazil, the USA, China, Canada, Colombia and
Thailand (Hause, Myers, Duff, & Hesse, 2016; Pasma, Davidson, &
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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Shaw, 2008; Saeng‐chuto, Rodtian, Temeeyasen, Wegner, & Nilubol,
2017; Sun, Vannucci, Knutson, Corzo, & Marthaler, 2017; Vannucci
et al., 2015; Wu et al., 2016). Clinical signs include vesicles on the
snout and coronary band, lameness, anorexia, lethargy and fever
(Hause et al., 2016). These are indistinguishable from those of other
notifiable vesicular diseases including foot‐and‐mouth disease (FMD)
(Alexandersen, Zhang, Donaldson, & Garland, 2003; Dekker, 2000;
Kitching, 2002) which can have a high economic impact (Knight‐
Jones & Rushton, 2013).
Rapid and accurate detection of SVV‐1 is necessary to confirm
the disease causing agent, and to initiate the implementation of
control processes. Virus isolation on cell cultures (Hales et al.,
2008; Knowles et al., 2012), conventional and real‐time RT‐PCR
(rRT‐PCR) assays (Bracht, O'Hearn, Fabian, Barrette, & Sayed,
2016; Dall Agnol, Otonel, Leme, Alfieri, & Alfieri, 2017; Fowler et
al., 2017; Gimenez‐Lirola et al., 2016) and full genome sequencing
(Hales et al., 2008) have all been used to identify and investigate
SVV‐1 isolates. A number of accurate and sensitive rRT‐PCR
methods have been developed, targeting the viral polymerase 3D
region (Fowler et al., 2017), the VP1 coding region (Bracht et al.,
2016), and the 5′ untranslated region (5′‐UTR) (Gimenez‐Lirola et
al., 2016). However, diagnosis via these methods relies on the
transport of samples under appropriate conditions from the point
of collection to centralized laboratory settings, which may add a
significant time delay and favour the spread of disease, particularly
considering that modes of transmission have not yet been fully
elucidated (Yoon, 2015).
The development of rapid, cost‐effective diagnostic assays that
can be used at the point of sample collection has been identified as
a gap in preparedness for the control of SVV‐1 (Yoon, 2015). Rev-
erse transcription loop‐mediated isothermal amplification (RT‐LAMP)
is able to rapidly amplify RNA with high specificity and efficiency
under isothermal conditions at a single temperature, for example in a
water bath (Notomi et al., 2000), and allows the simple, rapid and
cost‐effective detection of disease causing agents at the point of
sample collection. A number of LAMP assays have been developed
for veterinary pathogens such as foot‐and‐mouth disease virus
(FMDV) (Dukes, King, & Alexandersen, 2006; Howson et al., 2017),
African horse sickness virus (Fowler et al., 2016) and African swine
fever (James et al., 2010), and some shown to be effective when
deployed in field settings using simple sample preparation methods
(Howson et al., 2017). This study describes the development of two
RT‐LAMP assays using lyophilized reagents, targeting the 5′‐untrans-
lated region (5′UTR) and virus protein (VP) 3‐1 regions for the detec-
tion of SVV‐1, and performed on a portable real‐time fluorometer
suitable for field use.
2 | MATERIALS AND METHODS
2.1 | Ethics
Samples used in this study (Table 1) were archival samples previously
submitted to the World Reference Laboratory for FMD (WRLFMD;
The Pirbright Institute, UK).
2.2 | Virus isolates
SVV‐1 cell culture isolates were obtained from archival stocks held in
WRLFMD repository (Table 1). For evaluation of direct detection, clin-
ical samples were not available for this study, and therefore isolates
were diluted 1/100 in negative pig epithelium tissue suspension (10%
[w/v] diluted in M25 phosphate buffered saline: 35 mM Na2HPO4,
5.7 mM KH2PO4; pH 7.6). This was to simulate an original suspension
(OS) sample that would be prepared by homogenization of swine
epithelium tissue either in the field, for example using the SVANO-
DIP® Ag Extraction kit (Svanova), or in the laboratory, before testing.
A panel of other viruses that cause similar clinical signs to SVV‐1,
including swine vesicular disease virus (SVDV): UKG/179/73 and ITL/
16/2006; FMD virus (FMDV): O/MAY/13/2012, A/ZAM/1/2015, SAT
2/ZAM/2/2015, SAT 3/ZAM/3/2015, ASIA 1/PAK/37/2015; vesicular
stomatitis New Jersey virus (VSNJV): 29344/Colombia/2000; vesicular
stomatitis Indiana virus (VSIV): 29356/Colombia/2000; and African
swine fever virus (ASFV): W2/16/01 was used to evaluate the speci-
ficity of the SVV‐1 RT‐LAMP.
2.3 | RT‐LAMP primer design
Thirty‐nine published SVV‐1 full genomes (Accession numbers:
DQ641257, KC667560, KT321458, KY419132, KY038016, KX37
7924, KX857728, KY747512, KY747511, KY747510, KX751945,
TABLE 1 Seneca valley virus 1 cell‐culture isolates used for bench validation of the RT‐LAMP assays
Sample name Virus Origin Date of collection P1 Tp P1 Ta P2 Tp P2 Ta SVV‐1 rRT‐PCRa
NC‐88‐23626 SVV‐1 North Carolina, USA 1988 06:45 87.7 08:00 86.3 21.90
NJ‐90‐10324 SVV‐1 New Jersey, USA 1990 06:30 87.7 06:30 86.3 21.04
CA‐01‐131395 SVV‐1 California, USA 2001 06:15 87.9 06:15 86.0 19.05
LA‐97‐1278 SVV‐1 Louisiana, USA 1997 05:45 87.9 07:00 86.3 19.89
IA‐89‐47552 SVV‐1 Iowa, USA 1989 06:00 87.7 06:15 86.4 19.40
IL‐92‐48963 SVV‐1 Illinois, USA 1992 06:45 87.9 06:30 86.2 20.94
MN‐88‐36695 SVV‐1 Minnesota, USA 1988 06:30 87.8 06:15 86.3 20.20
Notes. P1: primer set 1, P2: primer set 2, n/d: not done.
aSVV‐1 samples were diluted 1/100 in negative pig epithelium tissue suspension, and all samples underwent RNA extraction. rRT‐PCR results are the
means of two replicates.
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KX751944, KX751943, KT757282, KT757281, KT757280,
KX778101, KX019804, KU058183, KU058182, KU359214, KU359
213, KU359212, KU359211, KU359210, KR063109, KR063108,
KR063107, KY486165, KY486164, KY486163, KY486162,
KY486161, KY486160, KY486159, KY486158, KY486157,
KY486156, KY486166) and ten unpublished SVV‐1 full genomes
(KU954090, KU954089, KU954088, KU954087, KU954086,
KX751946, KX223836, KX173340, KX173339, KX173338) were
obtained from GenBank (http://www.ncbi.nlm.nih.gov), and used for
design of the RT‐LAMP primers. Sequences were aligned in ClustalX
(v.2.0.10) and a consensus sequence was generated. LAMP Designer
(OptiGene Ltd, UK) was used to design six sets of RT‐LAMP primers,
three with GenBank accession DQ641257 as a reference: primer
sets 1‐3 (P1‐P3), and three with the consensus sequence as a refer-
ence: primer sets 4‐6 (P4‐P6).
2.4 | RNA extraction
RNA was extracted using the MagMAX™‐96 Viral RNA Isolation Kit
(ThermoFisher Scientific, UK) according to manufacturer's instruc-
tions, utilizing a MagMAX™ Express 96 Extraction Robot (Thermo-
Fisher Scientific, UK). To determine the analytical sensitivity, a
tenfold dilution series (10−1–10−9) was made of RNA extracted from
SVV‐1 isolates NC‐88‐23626 and LA‐97‐1278 (Table 1) diluted in
nuclease‐free water (NFW) containing carrier RNA (1 μg/μl, Qiagen).
RNA dilution series was tested in triplicate using the rRT‐PCR and
RT‐LAMP assays.
2.5 | Reverse transcription loop‐mediated
isothermal amplification
The 25 μl Reverse transcription loop‐mediated isothermal amplifica-
tion (RT‐LAMP) reaction mix comprised 15 μl of isothermal master-
mix ISO‐001 (Optigene Ltd., UK) containing 7.5 units of OptiRT
enzyme (Optigene Ltd., UK), 2.5 μl of 10× the primer set to be
tested, 2.5 μl NFW and 5 μl of RNA/diluted OS template. Primer
sets contained 2.0 μM each of forward and reverse inner primers
(FIP and BIP respectively), 0.2 μM each of forward and reverse
outer primers (F3 and B3 respectively), and 1.0 μM each of forward
and reverse loop primers (LF and LB respectively). The ‘wet’ assay
format containing P1 or P2 was used for bench validation (VK‐
001RT‐SVV‐1‐050, Optigene Ltd., UK). Nucleotide positions for all
primers in P1 and P2 mapped to GenBank accession no. DQ641257
are shown in Figure 1. RT‐LAMP reactions were performed on a
battery powered, portable Genie® II (OptiGene Ltd., UK), at 63°C
for 30 min. A positive reaction was signified by an exponential
increase in fluorescence (δR). The time to positivity (Tp) was deter-
mined by the peak fluorescence ratio on the amplification rate
curve, with a threshold value of 0.02. To confirm the specificity of
the SVV‐1 amplicons, anneal temperatures (Ta) were calculated for
all reactions, after a melt curve analysis was carried out by heating
RT‐LAMP products to 98°C for 1 min, then cooling to 80°C decreas-
ing at 0.05°C/s. All RT‐LAMP analysis was performed using Genie®
Explorer v0.2.1.1 software (OptiGene Ltd., UK).
2.6 | Lyophilized RT‐LAMP reagents
Freeze‐dried RT‐LAMP reaction mixes (VK‐DR001RT‐SVV‐1‐100,
Optigene Ltd., UK) were prepared to include either primer set 1 (P1)
or primer set 2 (P2) using proprietary lyophilization reagents. Each
reaction was resuspended with 20 μl of resuspension buffer on use.
Five μl of RNA/diluted OS template was subsequently added to each
reaction.
2.7 | Real‐time reverse transcription PCR
Real‐time reverse transcription PCR (rRT‐PCR) assays were carried
out as described previously (Fowler et al., 2017), with primers and a
probe targeting the conserved 3D region of SVV‐1, using the Super-
Script® III Platinum® One‐Step qRT‐PCR Kit reaction mix on an
Applied Biosystems 7500 Fast real‐time PCR instrument (Applied
Biosystems, UK).
F IGURE 1 Oligonucleotide primers used for RT‐LAMP amplification of SVV‐1. (a) Primer set 1 (P1) targeting the 5′UTR region; (b) Primer
set 2 (P2), targeting the VP3‐1 region. Nucleotide positions of the primers in both primer sets (P1 and P2) are mapped to GenBank accession
number DQ641257 [Colour figure can be viewed at wileyonlinelibrary.com]
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2.8 | Direct detection by RT‐LAMP
Twofold dilutions of cell culture isolates NC‐88‐23626 and LA‐97‐
1278 already diluted 1/100 in negative pig epithelium tissue suspen-
sion (subsequently referred to as ‘neat’), were prepared as template for
the RT‐LAMP reaction in the absence of RNA extraction, to evaluate
simple sample preparation suitable for field use. Extracted RNA (as
described above) from these ‘neat’ samples was used as a comparison.
3 | RESULTS
3.1 | RT‐LAMP optimization
Six primer sets targeting differing regions of the SVV‐1 genome were
initially investigated using extracted RNA from the seven SVV‐1 iso-
lates in Table 1 (data not shown). Only primer sets P1 and P2, tar-
geting the 5′‐UTR and VP3‐1 regions, respectively, produced
positive results, with a similar Tp across all samples and were conse-
quently chosen for further evaluation. A positive sample was defined
when amplification occurred, with a SVV‐1 amplicon‐specific anneal
temperature (Ta) (P1: mean Ta 87.9 ± 0.15, P2: mean Ta 86.5 ± 0.13
for 35 SVV‐1‐positive RT‐LAMP reactions).
3.2 | Analytical sensitivity
A log10 serial dilution series of RNA extracted from samples NC‐88‐
23626 and LA‐97‐1278 was used to compare the analytical sensitivity
of the SVV‐1 RT‐LAMP using P1 and P2, with the rRT‐PCR (Table 2).
A higher analytical sensitivity was observed for P1, compared to P2
for both samples tested. The rRT‐PCR showed higher analytical sensi-
tivity than both primer sets of the RT‐LAMP by at least one log10 dilu-
tion (P1: LA‐97‐1278), and up to three log10 dilutions (P2).
3.3 | Diagnostic sensitivity and specificity
RNA extracted from seven SVV‐1 cell culture isolates diluted 1/100 in
negative pig epithelium tissue suspension (Table 1), and a panel of
other viruses that cause similar clinical signs (SVDV, FMDV, VSNJV,
VSIV and ASFV) was used to evaluate the sensitivity and specificity of
the SVV‐1 RT‐LAMP using both primer sets. There was 100% agree-
ment between P1 and P2 by RT‐LAMP with the rRT‐PCR for the SVV‐
1‐positive samples, where a positive result was observed as early as
5:45 and 6:15 min for P1 and P2, respectively. No false positive results
were observed for 10/10 of the known positive virus samples and the
negative pig epithelium tissue suspension sample for either primer set.
3.4 | Direct detection by RT‐LAMP
Simple preparation of samples was evaluated, where OS samples
were added directly, or after dilution in nuclease‐free water (NFW),
prior to RT‐LAMP. For P1, the addition of neat OS resulted in com-
plete inhibition of the RT‐LAMP, with no amplification observed (Fig-
ure 2). The lowest Tp was achieved at a 1/20 dilution (Tp: 8:45 min),
an increase in Tp of 1:15 min when compared to the addition of
extracted RNA. For P2, a positive result was observed for all dilu-
tions, with the lowest Tp achieved at a 1/8 dilution (Tp: 7:28 min),
equivalent to the extracted RNA. Tp values were similar between
dilutions of 1/8–1/20 for both primer sets.
3.5 | Evaluation of lyophilized RT‐LAMP reagents
Diagnostic and analytical sensitivity, and direct detection methods
were also evaluated using lyophilized reagents and compared with
‘wet’ reagents. For the seven SVV‐1 samples available, the perfor-
mance of both assays was comparable (Figure 3), and the limit of
detection was equivalent when using P1; however for P2, one log10
reduction in analytical sensitivity was observed using lyophilized
reagents. For both primer sets, an increase in Tp > 1 min for all dilu-
tions was observed. When samples were added directly to lyophi-
lized reagents, Tp values were comparable at the higher dilutions (1/
4–1/20); however when the sample was added either neat (P1 and
P2) or at a 1/2 (P1) dilution, a reduction in inhibition was observed,
with amplification occurring earlier, than when compared to using
‘wet’ reagents (Figure 2).
TABLE 2 Analytical sensitivity of the two SVV-1 RT‐LAMP assays using either P1 or P2 and compared to the rRT‐PCR
Sample/test Primer set
Dilution
10−1 10−2 10−3 10−4 10−5 10−6 10−7 10−8 10−9
NC‐88‐23626
RT‐LAMP (Tp) P1 07:30 07:20 08:00 09:00 12:25 12:45a 12:30a No Tp No Tp
P2 06:55 07:40 09:05 10:35 16:45a No Tp No Tp No Tp No Tp
rRT‐PCR (CT) 18.97 22.29 25.67 29.01 32.30 35.67 38.49 40.86a Undet.
LA‐97‐1278
RT‐LAMP (Tp) P1 06:50 07:10 08:30 09:05 11:20 14:50 12:15a No Tp No Tp
P2 08:05 09:10 10:50 13:35 No Tp No Tp No Tp No Tp No Tp
rRT‐PCR (CT) 17.00 20.24 23.57 26.96 30.45 33.74 37.19 39.85b Undet.
Notes. Values are means of three replicates. NC‐88‐23626 and LA‐97‐1278 are SVV‐1 isolates.
P1: primer set 1, P2: primer set 2.
aCT/Tp values for only one well.
bCT/Tp values for only two wells. Undet. CT value undetermined by rRT‐PCR.
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4 | DISCUSSION
Rapid detection of SVV‐1 is important to identify the infectious
agent, and to differentiate between clinically indistinguishable notifi-
able diseases such as FMD. An incorrect diagnosis may have severe
consequences, including the type of control strategies implemented
and financial implications (Anderson, 2002; Ferris, King, Reid, Shaw,
& Hutchings, 2006). A number of sensitive molecular assays for the
detection of SVV‐1 have been previously reported (Bracht et al.,
2016; Dall Agnol et al., 2017; Fowler et al., 2017; Gimenez‐Lirola et
al., 2016; Hales et al., 2008); however, samples must be transported
to laboratories for testing, delaying the time to result. This study
described the development and bench validation of sensitive and
specific RT‐LAMP assays for the detection of SVV‐1 that may be
performed at the point of sample collection, enabling a positive
result in under 9 min.
Six primer sets were designed targeting different conserved
regions of the SVV‐1 genome, including the 5′‐UTR, VP3‐1, VP1 and
3D regions, based on available sequences from Genbank and the
rRT‐PCR assays previously described (Bracht et al., 2016; Dall Agnol
et al., 2017; Fowler et al., 2017; Gimenez‐Lirola et al., 2016). The
two most sensitive primer sets, P1 and P2, target the 5′‐UTR and
VP3‐1 regions, respectively, which have also been the target of
choice for molecular diagnostic tests for other picornaviruses, includ-
ing FMDV (King et al., 2006; Reid et al., 2014), SVDV (Reid, Ferris,
Hutchings, King, & Alexandersen, 2004) and human rhinovirus (Boch-
kov, Grindle, Vang, Evans, & Gern, 2014). Both assays were able to
demonstrate amplification of neat samples diluted 1/100 in negative
pig epithelium tissue suspension in under eight minutes, when RNA
was extracted prior to the RT‐LAMP assay. No false positive amplifi-
cation was observed for the other viruses tested. Diagnostic sensitiv-
ity was 100% for both assays when compared to a recently
developed rRT‐PCR (Fowler et al., 2017), using the seven samples
that were available for this study. As this is a small sample size, it is
recommended that these assays be further evaluated using more
samples of different types, taken from a wider geographical
distribution.
The analytical sensitivity of the SVV‐1 RT‐LAMP using primer set
P1 was found to be at least one‐log10 higher than the analytical sen-
sitivity of the SVV‐1 RT‐LAMP when using primer set P2, for the
two samples tested, and at least one‐log10 lower than the rRT‐PCR
(Fowler et al., 2017). However, for the dilutions that were not
detected in all replicates by RT‐LAMP, for example 10−7 and 10−8,
high CT values were observed when tested with the rRT‐PCR (>37
CT average) suggesting a low level of virus was present. Although
F IGURE 2 Comparison of ‘wet’ and lyophilized reagents using
direct detection by RT‐LAMP with primer set 1 (a) and primer set 2
(b). Black bars represent ‘wet’ reagents and grey bars represent
lyophilized reagents. Neat: SVV‐1 sample NC‐88‐23626 diluted 1/100
in negative pig epithelium tissue suspension to simulate a natural
original suspension sample. This ‘neat’ sample was then diluted ½, ¼,
1/8, 1/10, 1/16 and 1/20 in nuclease‐free water (NFW) and compared
to extracted RNA from the ‘neat’ sample as a positive control
F IGURE 3 A box‐plot to compare Tp values of ‘wet’ and
lyophilized reagents for primer sets 1 (P1) and 2 (P2) using extracted
RNA from the seven SVV‐1 samples. SVV‐1 samples were diluted 1/
100 in negative pig epithelium tissue suspension prior to RNA
extraction
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the SVV‐1 RT‐LAMP demonstrates a slightly lower sensitivity than
the rRT‐PCR, samples from clinical cases are likely to contain high
viral loads, and therefore RT‐LAMP has the capacity to be a useful
tool in the rapid diagnosis of SVV‐1.
To enable the potential of these assays to be employed for rapid
detection in the field, simple sample preparation methods were
investigated to negate the requirement for RNA extraction, which
may be difficult to perform in field conditions. For the rapid detec-
tion of FMDV from clinical samples, previous studies demonstrated
that a 1/5 dilution of epithelium tissue suspension or serum, and a 1/
10 dilution of oesophageal–pharyngeal fluid, in NFW, was sufficient
to reduce the inhibitory effect observed by the addition of a neat
sample to the RT‐LAMP (Howson et al., 2017; Waters et al., 2014).
This study therefore investigated whether this methodology could
also be applied to the SVV‐1 RT‐LAMP assays, using a twofold dilu-
tion series. As clinical samples were not available for this study, iso-
lates were diluted 1/100 in negative pig epithelium tissue suspension
to simulate an original suspension (OS) sample that would be pre-
pared by homogenization of swine epithelium tissue either in the
field, for example using the SVANODIP® Ag Extraction kit (Svanova),
or in the laboratory, before testing. When these samples were added
directly to the RT‐LAMP, no amplification was observed for P1, and
there was delayed amplification when using P2, likely due to con-
taminants present in the sample causing reaction inhibition. Further
dilution of the sample enabled amplification, with an optimum dilu-
tion of 1/16 for P1 and 1/8 for P2. Although a slight delay to amplifi-
cation was evident using these dilutions when compared to using
RNA extraction coupled with RT‐LAMP, time from sample receipt to
amplification was achieved within 12 min, highlighting the potential
of these assays for rapid field diagnosis. However, further validation
is required using a variety of field samples, including epithelial tissue
samples, serum and vesicular swabs, to check for inhibitory effects
from contaminants such as soil and faeces.
To overcome the difficulties of using temperature‐sensitive ‘wet’
reagents in molecular assays employed in field settings, many studies
have evaluated the use of thermostable lyophilized reagents that do
not require the maintenance of a cold chain (Armson et al., 2017;
Goller et al., 2018; Howson et al., 2018; Semper et al., 2016). Lyo-
philized and ‘wet’ reagents demonstrated comparable performance
to one another when the seven available SVV‐1 samples were
tested, and when diluted samples (>1/4) were added directly to the
RT‐LAMP. Additionally, when a sample was added either neat or
diluted 1/2 in nuclease‐free water, the amplification inhibition
observed with ‘wet’ reagents was reduced when replaced with lyo-
philized reagents. This provides an indication that a lyophilized SVV‐
1 RT‐LAMP could be utilized as an efficient and rapid diagnostic
tool. However, it is recommended that these lyophilized assays are
validated on a variety of sample types and viral loads in field
settings.
In conclusion, this study describes the development of RT‐LAMP
assays for the rapid detection of SVV‐1, suitable for employment in
field settings. These assays could be performed alongside field tests
for FMD (Ambagala et al., 2016; Howson et al., 2017, 2018; Madi et
al., 2012; Paixão et al., 2008), providing a rapid alternative diagnosis
when FMD is negated. RT‐LAMP can be performed on a portable
real‐time fluorometer, with results achieved in under 12 min, remov-
ing the requirement for RNA extraction. Furthermore, the use of lyo-
philized reagents enables rapid and simple methodology.
Deployment of these RT‐LAMP assays into in situ settings could
assist in disease control by enabling simple, rapid and highly sensitive
detection of SVV‐1.
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